
  
    
      
        Background_NNP
        Central_NNP venous_JJ catheters_NNS (_( CVCs_NNP )_) are_VBP widely_RB used_VBN in_IN
        critically_RB ill_JJ patients_NNS throughout_IN the_DT developed_VBN world_NN ._.
        They_PRP permit_VBP hemodynamic_JJ monitoring_NN and_CC allow_VB access_NN for_IN the_DT
        administration_NN of_IN fluids_NNS ,_, blood_NN products_NNS ,_, medications_NNS ,_, and_CC
        total_JJ parenteral_NN nutrition_NN (_( TPN_NNP )_) ._. Estimates_NNS of_IN their_PRP$ use_NN in_IN
        the_DT United_NNP States_NNPS alone_RB suggest_VBP that_IN over_IN five_CD million_CD CVCs_NNP
        are_VBP inserted_VBN annually_RB [_NN 1_CD 2_CD ]_NN ._. Although_IN CVCs_NNP have_VBP
        significant_JJ benefits_NNS in_IN many_JJ clinical_JJ situations_NNS ,_, the_DT
        increase_NN in_IN their_PRP$ use_NN over_IN the_DT last_JJ 20_CD years_NNS has_VBZ been_VBN
        associated_VBN with_IN at_IN least_JJS a_DT doubling_NN of_IN resultant_JJ nosocomial_NN
        infections_NNS [_NN 3_CD 4_CD ]_NN ._. A_DT number_NN of_IN factors_NNS may_MD contribute_VB to_TO
        the_DT risk_NN of_IN catheter_NN related_VBD infections_NNS (_( CRI_NNP )_) [_NN 5_CD 6_CD 7_CD 8_CD 9_CD ]_NN
        ._. Although_IN a_DT common_JJ problem_NN ,_, the_DT descriptive_JJ epidemiology_NN ,_,
        pathophysiology_NN ,_, risk_NN factors_NNS and_CC best_JJS means_NNS of_IN diagnosing_VBG
        CRI_NNP have_VBP not_RB yet_RB been_VBN fully_RB elucidated_JJ ._. We_PRP undertook_VBD a_DT
        prospective_JJ study_NN of_IN all_DT new_JJ CVCs_NNP inserted_VBD into_IN patients_NNS in_IN
        the_DT intensive_JJ care_NN units_NNS (_( ICU_NNP )_) ,_, in_IN order_NN to_TO identify_VB the_DT
        risk_NN factors_NNS and_CC to_TO determine_VB the_DT effect_NN of_IN glycopeptide_NN
        antibiotics_NNS on_IN CRI_NNP ._.
      
      
        Patients_NNS and_CC Methods_NNP
        Human_JJ research_NN ethics_NNS committee_NN approval_NN was_VBD obtained_VBN
        for_IN the_DT study_NN ._. As_IN there_EX were_VBD no_DT interventions_NNS ,_, requirement_NN
        for_IN written_VBN patient_NN consent_NN was_VBD waived_VBN ._. All_DT patients_NNS
        admitted_VBN to_TO medical_JJ ,_, neurosurgical_JJ and_CC surgical_JJ ICUs_NNP of_IN
        Istanbul_NNP Faculty_NN of_IN Medicine_NNP between_IN January_NNP 2001_CD and_CC
        December_NNP 2001_CD who_WP submitted_VBD to_TO a_DT CVC_NNP were_VBD included_VBN in_IN the_DT
        study_NN ._. The_DT catheters_NNS used_VBN were_VBD nontunneled_JJ ,_, noncuffed_JJ ,_,
        triple_JJ lumen_NN and_CC made_VBN of_IN polyurethane_NN material_NN (_( Arrow_NNP ,_,
        Erding_NNP ,_, Germany_NNP )_) ._. All_DT catheters_NNS were_VBD inserted_VBN via_IN new_JJ
        percutaneous_JJ puncture_NN in_IN intensive_JJ care_NN units_NNS by_IN
        experienced_VBN anaesthetists_NNS under_IN strict_JJ aseptic_JJ techniques_NNS ._.
        After_IN washing_VBG hands_NNS and_CC forearms_NNS with_IN antiseptic_JJ soap_NN ,_,
        drying_VBG with_IN a_DT sterile_JJ towel_NN ,_, maximal_NN sterile_JJ barrier_NN
        precautions_NNS (_( sterile_JJ gloves_NNS ,_, longsleeved_JJ sterile_JJ gown_NN ,_,
        mask_NN ,_, cap_NN ,_, and_CC large_JJ sterile_JJ sheet_NN drape_NN )_) were_VBD observed_VBN
        prior_RB to_TO catheter_NN insertion_NN ._. Povidone-iodine_NNP was_VBD used_VBN as_IN
        antiseptic_JJ for_IN cleansing_VBG the_DT CVC_NNP insertion_NN site_NN ._. After_IN
        catheter_NN insertion_NN the_DT site_NN was_VBD covered_VBN with_IN sterile_JJ gauze_NN ._.
        Every_DT 48_CD hours_NNS the_DT dressing_VBG was_VBD removed_VBN ,_, the_DT site_NN was_VBD
        inspected_VBN and_CC cleansed_VBN with_IN povidone-iodine_JJ ,_, and_CC a_DT new_JJ
        dressing_VBG was_VBD applied_VBN ._. Catheters_NNP were_VBD followed_VBN for_IN the_DT
        duration_NN of_IN their_PRP$ insertion_NN and_CC data_NNS were_VBD obtained_VBN daily_JJ on_IN
        inflammation_NN of_IN the_DT catheter_NN sites_NNS by_IN a_DT single_JJ observer_NN ._.
        The_DT catheters_NNS were_VBD removed_VBN at_IN the_DT end_NN of_IN the_DT day_NN seven_CD as_IN
        scheduled_VBN replacement_NN is_VBZ followed_VBN in_IN the_DT ICUs_NNP of_IN our_PRP$
        hospital_NN ._. Catheters_NNP were_VBD removed_VBN in_IN less_JJR than_IN seven_CD days_NNS
        when_WRB the_DT patient_NN had_VBD no_DT more_JJR need_NN for_IN central_JJ line_NN and_CC
        suspected_VBN to_TO have_VB CRI_NNP ._. There_EX was_VBD provision_NN for_IN
        discretionary_JJ clinical_JJ judgement_NN to_TO leave_VB the_DT catheter_NN
        longer_JJR than_IN seven_CD days_NNS ._. Each_DT CVC_NNP was_VBD withdrawn_VBN aseptically_RB
        using_VBG sterile_JJ forceps_NNS after_IN the_DT area_NN of_IN insertion_NN was_VBD
        washed_VBN with_IN povidone_NN -_: iodine_NN solution_NN ._. The_DT distal_NN 5_CD cm_NN of_IN
        the_DT catheter_NN was_VBD cut_VBN off_RP using_VBG sterile_JJ scissor_NN and_CC sent_VBD
        aseptically_RB to_TO the_DT clinical_JJ microbiology_NN laboratory_NN where_WRB
        it_PRP was_VBD cultured_JJ by_IN semiquantitative_JJ method_NN [_NN 10_CD ]_NN ._. When_WRB
        blood_NN cultures_NNS were_VBD indicated_VBN ,_, 10_CD mL_NN of_IN venous_JJ blood_NN was_VBD
        drawn_VBN from_IN catheter_NN and_CC from_IN two_CD peripheral_JJ veins_NNS following_VBG
        skin_NN preparation_NN with_IN povidone-iodine_JJ ._. Data_NNP were_VBD also_RB
        obtained_VBN on_IN patients_NNS age_NN ,_, gender_NN ,_, unit_NN ,_, primary_JJ diagnosis_NN
        on_IN admission_NN (_( categorized_VBN as_IN cardiorespiratory_NN failure_NN ,_,
        trauma_NN ,_, postsurgical_JJ and_CC others_NNS )_) ,_, CVC_NNP insertion_NN site_NN ,_,
        whether_IN it_PRP was_VBD the_DT first_JJ or_CC a_DT subsequent_JJ catheter_NN ,_, duration_NN
        of_IN catheterization_NN and_CC glycopeptide_NN antibiotic_JJ usage_NN ._.
      
      
        Definition_NNP 1_CD 3_CD
        Colonized_NNP catheter_NN :_: Growth_NN of_IN ≥_NN 15_CD colony_NN forming_VBG units_NNS
        (_( cfu_NN )_) on_IN semiquantitative_JJ culture_NN from_IN catheter_NN tip_NN in_IN the_DT
        absence_NN of_IN accompanying_VBG clinical_JJ symptoms_NNS ._.
        Exit_NN site_NN infection_NN :_: Erythema_NNP ,_, tenderness_NN ,_, induration_NN ,_,
        or_CC purulence_NN within_IN 2_CD cm_NN of_IN the_DT skin_NN at_IN the_DT exit_NN site_NN of_IN
        the_DT catheter_NN ._.
        Definite_NNP catheter-related_JJ bacteremia_NN (_( D-CRB_NNP )_) :_: Isolation_NNP
        of_IN the_DT same_JJ organism_NN (_( i_NNP ._. e_SYM ._. ,_, identical_JJ species_NNS ,_,
        antibiograms_NNS )_) from_IN semiquantative_JJ culture_NN of_IN the_DT catheter_NN
        and_CC from_IN the_DT blood_NN (_( drawn_VBN from_IN a_DT peripheral_JJ veins_NNS )_) of_IN a_DT
        patient_NN with_IN accompanying_VBG clinical_JJ symptoms_NNS of_IN bloodstream_NN
        infection_NN and_CC no_DT other_JJ apparent_JJ source_NN of_IN infection_NN ._.
        Possible_JJ catheter-related_JJ bacteremia_NN (_( P-CRB_NNP )_) :_: Bacteremia_NNP
        (_( isolation_NN of_IN the_DT same_JJ organism_NN with_IN identical_JJ antibiograms_NNS
        from_IN the_DT blood_NN drawn_VBN from_IN peripheral_JJ veins_NNS and_CC CVC_NNP )_) ,_,
        clinical_JJ manifestations_NNS of_IN sepsis_NN ,_, defervescence_NN after_IN
        removal_NN of_IN implicated_VBN catheter_NN ,_, but_CC no_DT laboratory_NN
        confirmation_NN of_IN CVC_NNP colonization_NN ._.
      
      
        Statistical_NNP analysis_NN
        The_DT chi-square_JJ or_CC the_DT Fisher_NNP 's_POS test_NN was_VBD used_VBN to_TO
        determine_VB the_DT significant_JJ differences_NNS between_IN categorical_JJ
        variables_NNS ._. Mann-_NNP Whitney_NNP U_NNP test_NN was_VBD used_VBN for_IN the_DT continuous_JJ
        variables_NNS ._. The_DT variables_NNS that_WDT were_VBD found_VBN to_TO be_VB significant_JJ
        (_( p_NN ≤_NN 0_CD ._. 05_CD )_) in_IN the_DT univariate_NN analysis_NN (_( catheter_NN insertion_NN
        site_NN ,_, duration_NN of_IN catheterization_NN and_CC glycopeptide_NN usage_NN )_)
        were_VBD taken_VBN into_IN logistic_JJ regression_NN ._. The_DT software_NN package_NN
        used_VBN for_IN statistical_JJ analysis_NN was_VBD SPSS_NNP for_IN Windows_NNP Release_NNP
        10_CD ._. 0_CD (_( SPSS_NNP Inc_NNP ._. ,_, Chicago_NNP ,_, IL_NNP ._. ,_, U_NNP ._. S_NNP ._. A_DT ._. )_) ._.
      
      
        Results_NNS
        During_IN the_DT study_NN period_NN 300_CD patients_NNS with_IN CVCs_NNP were_VBD
        assessed_VBN ._. One_CD hundred_CD and_CC seventy_NN -_: six_CD (_( 58_CD ._. 6_CD %_NN )_) of_IN the_DT
        patients_NNS were_VBD from_IN the_DT general_JJ ICU_NNP ,_, 92_CD (_( 30_CD ._. 7_CD %_NN )_) were_VBD from_IN
        the_DT surgical_JJ ICU_NNP and_CC the_DT other_JJ 32_CD (_( 10_CD ._. 7_CD %_NN )_) were_VBD from_IN the_DT
        neurosurgical_JJ ICU_NNP ._. The_DT patients_NNS studied_VBN were_VBD 148_CD (_( 49_CD ._. 3_LS %_NN )_)
        males_NNS and_CC 152_CD (_( 51_CD ._. 7_CD %_NN )_) females_NNS ._. The_DT mean_JJ age_NN was_VBD 44_CD ±_NN 21_CD ._. 1_LS ._.
        The_DT primary_JJ diagnosis_NN of_IN the_DT patients_NNS were_VBD as_IN follows_VBZ ;_: 81_CD
        (_( 27_CD %_NN )_) cardiorespiratory_NN failure_NN ,_, 72_CD (_( %_NN 24_CD )_) trauma_NN ,_, 72_CD (_( 24_CD %_NN )_)
        postsurgical_JJ and_CC 75_CD (_( 25_CD %_NN )_) others_NNS ._. CVCs_NNP were_VBD inserted_VBN either_CC
        into_IN jugular_NN vein_NN (_( n_NN =_SYM 132_CD ,_, 44_CD %_NN )_) or_CC into_IN the_DT subclavian_NN
        vein_NN (_( n_NN =_SYM 168_CD ,_, 56_CD %_NN )_) ._. Twenty_CD -_: eight_CD (_( 9_CD ._. 3_LS %_NN )_) patients_NNS were_VBD
        receiving_VBG TPN_NNP ._. The_DT mean_JJ length_NN of_IN time_NN the_DT catheter_NN was_VBD
        kept_VBN in_IN place_NN was_VBD 7_CD ±_NN 2_CD ._. 8_CD days_NNS ._. Two_CD hundred_CD and_CC one_CD (_( 67_CD %_NN )_)
        CVCs_NNP were_VBD kept_VBN in_IN place_NN for_IN seven_CD days_NNS or_CC less_JJR and_CC the_DT
        other_JJ 99_CD (_( 33_CD %_NN )_) CVCs_NNP were_VBD kept_VBN in_IN place_NN for_IN more_JJR than_IN seven_CD
        days_NNS ._. Eighty_NNP four_CD (_( 28_CD %_NN )_) of_IN them_PRP at_IN the_DT time_NN of_IN catheter_NN
        insertion_NN ,_, a_DT total_NN of_IN 113_CD (_( 37_CD ._. 6_CD %_NN )_) patients_NNS were_VBD using_VBG
        glycopeptide_NN antibiotic_JJ during_IN catheterization_NN ._. The_DT other_JJ
        187_CD (_( 62_CD ._. 4_LS %_NN )_) patients_NNS were_VBD not_RB using_VBG glycopeptide_NN antibiotic_JJ
        at_IN the_DT time_NN of_IN catheter_NN insertion_NN and_CC for_IN the_DT duration_NN of_IN
        insertion_NN (_( Table_NNP 1_LS )_) ._.
        Ninety-one_NNP (_( 30_CD ._. 3_LS %_NN )_) of_IN the_DT CVCs_NNP were_VBD colonized_JJ and_CC the_DT
        CRI_NNP was_VBD found_VBN with_IN 50_CD (_( 16_CD ._. 7_CD %_NN )_) catheters_NNS ._. Of_IN the_DT CRIs_NNP ;_: 28_CD
        (_( %_NN 9_CD ._. 3_LS )_) D-CRB_NNP ,_, 8_CD (_( 2_CD ._. 7_CD %_NN )_) P-CRB_NNP and_CC 17_CD (_( 5_CD ._. 6_CD %_NN )_) exit_NN site_NN
        infection_NN was_VBD diagnosed_VBN ._. Three_CD (_( 1_CD %_NN )_) patients_NNS had_VBD both_DT D-CRB_NNP
        and_CC exit_NN site_NN infection_NN ._. The_DT unadjusted_JJ risk_NN ratios_NNS of_IN risk_NN
        factors_NNS are_VBP given_VBN in_IN Table_NNP 1_CD ._. No_DT significant_JJ difference_NN
        were_VBD found_VBN for_IN age_NN ,_, gender_NN ,_, unit_NN ,_, primary_JJ diagnosis_NN ,_,
        repeated_VBN catheterization_NN and_CC TPN_NNP use_NN ._. CRI_NNP was_VBD diagnosed_VBN
        with_IN higher_JJR rate_NN (_( n_NN =_SYM 30_CD ,_, 22_CD ._. 7_CD %_NN )_) in_IN CVCs_NNP inserted_VBD via_IN
        jugular_NN vein_NN in_IN comparison_NN with_IN subclavian_NN vein_NN (_( n_NN =_SYM 20_CD ,_,
        11_CD ._. 9_CD %_NN )_) (_( p_NN =_SYM 0_CD ._. 01_CD )_) ._. The_DT incidence_NN of_IN CRI_NNP (_( n_NN =_SYM 24_CD ,_, 24_CD ._. 2_LS %_NN )_) was_VBD
        higher_JJR in_IN catheters_NNS which_WDT were_VBD kept_VBN in_IN place_NN for_IN more_JJR than_IN
        seven_CD days_NNS (_( p_NN =_SYM 0_CD ._. 01_CD )_) ._. The_DT incidence_NN of_IN CRI_NNP was_VBD also_RB higher_JJR
        in_IN patients_NNS who_WP were_VBD not_RB using_VBG glycopeptide_NN antibiotic_JJ (_( n_NN =_SYM
        45_CD ,_, 24_CD ._. 0_CD %_NN )_) than_IN patients_NNS who_WP were_VBD using_VBG glycopeptide_NN
        antibiotic_JJ during_IN catheterization_NN (_( n_NN =_SYM 5_CD ,_, 4_CD ._. 4_CD %_NN )_) (_( p_NN =_SYM
        0_CD ._. 001_CD )_) ._. The_DT results_NNS of_IN the_DT multivariate_NN analysis_NN are_VBP
        broadly_RB in_IN agreement_NN with_IN the_DT univariate_NN analysis_NN (_( Table_NNP
        2_LS )_) ._. Use_NN of_IN a_DT jugular_NN insertion_NN site_NN has_VBZ an_DT odds_NNS ratio_NN of_IN
        2_CD ._. 52_CD (_( 95_CD %_NN CI_NNP :_: 1_CD ._. 32_CD -_: 4_CD ._. 81_CD ,_, p_NN =_SYM 0_CD ._. 005_CD )_) compared_VBN with_IN patients_NNS
        with_IN a_DT CVC_NNP inserted_VBD into_IN the_DT subclavian_NN vein_NN ._. Catheters_NNP
        kept_VBD in_IN place_NN for_IN more_JJR than_IN seven_CD days_NNS has_VBZ an_DT odds_NNS ratio_NN of_IN
        2_CD ._. 02_CD (_( 95_CD %_NN CI_NNP 1_CD ._. 05_CD -_: 3_CD ._. 87_CD ,_, p_NN =_SYM 0_CD ._. 03_CD )_) compared_VBN with_IN catheters_NNS
        kept_VBD in_IN place_NN for_IN seven_CD days_NNS or_CC less_JJR ._. When_WRB the_DT patients_NNS
        using_VBG glycopeptide_NN antibiotic_NN were_VBD taken_VBN as_IN the_DT reference_NN
        category_NN ,_, the_DT patients_NNS who_WP were_VBD not_RB using_VBG these_DT antibiotic_NN
        during_IN catheterization_NN had_VBD an_DT increased_VBN risk_NN with_IN an_DT odds_NNS
        ratio_NN of_IN 3_CD ._. 01_CD (_( 95_CD %_NN CI_NNP :_: 1_CD ._. 49_CD -_: 5_CD ._. 51_CD ,_, p_NN =_SYM 0_CD ._. 005_CD )_) ._.
        One_CD hundred_CD and_CC fourty-eight_JJ organisms_NNS were_VBD isolated_VBN as_IN
        the_DT cause_NN of_IN catheter_NN colonization_NN or_CC CRI_NNP ._. Seventy_CD -_: nine_CD
        (_( 53_CD ._. 4_LS %_NN )_) Gram-positive_NNP cocci_NN ,_, 66_CD (_( 44_CD ._. 5_LS %_NN )_) Gram-negative_NNP
        bacilli_NN and_CC three_CD (_( 2_CD ._. 1_LS %_NN )_) yeasts_NNS were_VBD isolated_VBN ._. The_DT most_RBS
        commonly_RB isolated_VBN organism_NN was_VBD 
        Staphylococcus_NNP aureus_NN (_( n_NN =_SYM 52_CD ,_, 37_CD ._. 1_LS %_NN )_)
        followed_VBN by_IN 
        Pseudomonas_NNP aeruginosa_NN (_( n_NN =_SYM 27_CD ,_,
        19_CD ._. 3_LS %_NN )_) ,_, 
        Staphylococcus_NNP epidermidis_NNS (_( n_NN =_SYM 26_CD ,_,
        %_NN 18_CD ._. 6_CD )_) and_CC 
        Acinetobacter_NNP spp_NN (_( n_NN =_SYM 21_CD ,_, %_NN 15_CD )_)
        (_( Table_NNP 3_LS )_) ._. Of_IN the_DT 50_CD cases_NNS of_IN CRI_NNP ,_, most_JJS of_IN the_DT organisms_NNS
        causing_VBG infection_NN were_VBD Gram-positive_NNP cocci_NN (_( n_NN =_SYM 38_CD ,_, 76_CD %_NN )_) ,_,
        with_IN the_DT most_RBS commonly_RB isolated_VBN organism_NN being_VBG 
        S_NNP ._. aureus_NN (_( n_NN =_SYM 32_CD ,_, 64_CD %_NN )_) (_( Table_NNP 3_LS )_) ._.
        All_DT of_IN the_DT 
        Staphylococcus_NNP spp_NN ._. were_VBD resistant_JJ to_TO
        methicilline_NN ._.
        The_DT etiology_NN of_IN CRI_NNP was_VBD predominantly_RB Gram-positive_NNP
        cocci_NN (_( n_NN =_SYM 32_CD ,_, 71_CD ._. 1_LS %_NN )_) in_IN patients_NNS who_WP were_VBD not_RB using_VBG
        glycopeptide_NN antibiotic_JJ during_IN catheterization_NN ._. In_IN
        contrast_NN ,_, in_IN patients_NNS who_WP were_VBD using_VBG glycopeptide_NN
        antibiotic_JJ during_IN catheterization_NN Gram-positive_NNP cocci_NN was_VBD
        only_RB responsible_JJ from_IN one_CD (_( %_NN 20_CD )_) CRI_NNP ._. This_DT difference_NN was_VBD
        significant_JJ (_( p_NN =_SYM 0_CD ._. 01_CD )_) ._.
      
      
        Discussion_NNP
        Many_JJ different_JJ risk_NN factors_NNS for_IN CRI_NNP in_IN intensive_JJ care_NN
        patients_NNS have_VBP been_VBN reported_VBN in_IN the_DT literature_NN [_NN 3_CD 4_CD 8_CD 9_CD 11_CD
        12_CD 13_CD ]_NN ._. These_DT include_VBP insertion_NN site_NN ,_, duration_NN of_IN
        catheterization_NN ,_, type_NN of_IN dressing_VBG ,_, type_NN of_IN catheter_NN ,_,
        frequent_JJ manipulations_NNS ,_, improper_JJ aseptic_JJ techniques_NNS ,_, number_NN
        of_IN catheter_NN lumens_NNS ,_, type_NN of_IN topical_JJ antiseptic_JJ solution_NN
        used_VBN and_CC use_NN of_IN the_DT catheter_NN for_IN TPN_NNP ._. The_DT relative_JJ
        importance_NN of_IN one_CD risk_NN factor_NN over_IN another_DT is_VBZ diffucult_NN to_TO
        assess_VB given_VBN that_IN in_IN most_JJS studies_NNS only_RB univariate_NN analysis_NN
        has_VBZ been_VBN performed_VBN and_CC estimates_NNS of_IN the_DT risk_NN of_IN each_DT factor_NN
        has_VBZ not_RB been_VBN attempted_VBN ._. We_PRP performed_VBD a_DT logistic_JJ regression_NN
        to_TO assess_VB the_DT major_JJ determinants_NNS of_IN CRI_NNP and_CC found_VBD that_IN the_DT
        independent_JJ predictors_NNS of_IN CRI_NNP were_VBD catheter_NN insertion_NN site_NN ,_,
        duration_NN of_IN catheterization_NN and_CC antibiotic_JJ (_( glycopeptide_NN )_)
        usage_NN ._.
        In_IN our_PRP$ study_NN infection_NN rates_NNS of_IN catheters_NNS inserted_VBN into_IN
        jugular_NN vein_NN and_CC subclavian_NN vein_NN were_VBD 22_CD ._. 7_CD %_NN ,_, 11_CD ._. 9_CD %_NN
        respectively_RB (_( p_NN =_SYM 0_CD ._. 005_CD )_) ._. The_DT CVCs_NNP inserted_VBD to_TO the_DT jugular_NN
        vein_NN were_VBD associated_VBN with_IN approximately_RB two_CD and_CC a_DT half_NN
        times_NNS the_DT risk_NN of_IN infection_NN compared_VBN with_IN CVC_NNP inserted_VBD to_TO
        subclavian_NN vein_NN in_IN the_DT multivariate_NN analysis_NN ._. It_PRP is_VBZ also_RB
        reported_VBN in_IN other_JJ studies_NNS that_WDT colonization_NN and_CC infection_NN
        is_VBZ more_RBR likely_JJ in_IN catheters_NNS inserted_VBN to_TO jugular_NN vein_NN than_IN
        in_IN catheters_NNS inserted_VBN to_TO subclavian_NN vein_NN [_NN 1_CD 3_CD 14_CD ]_NN ._.
        Reasons_NNS for_IN the_DT higher_JJR infection_NN rate_NN in_IN the_DT jugular_NN vein_NN
        site_NN is_VBZ thought_VBN to_TO be_VB related_VBN to_TO difficulty_NN keeping_VBG the_DT
        dressing_VBG in_IN place_NN and_CC contamination_NN with_IN oropharyngeal_NN
        secretions_NNS ._. Therefore_RB ,_, for_IN catheters_NNS inserted_VBN to_TO jugular_NN
        vein_NN ,_, the_DT manipulations_NNS should_MD be_VB done_VBN with_IN more_JJR caution_NN
        and_CC the_DT oropharyngeal_NN secretions_NNS should_MD be_VB prevented_VBN to_TO
        contaminate_NN the_DT catheter_NN ._. Most_JJS of_IN the_DT phycians_NNS select_VBP the_DT
        jugular_NN vein_NN for_IN catheter_NN insertion_NN because_IN it_PRP is_VBZ easier_JJR to_TO
        insert_VB the_DT catheter_NN and_CC due_JJ to_TO low_JJ mechanical_JJ complication_NN
        rate_NN ._. According_VBG to_TO our_PRP$ study_NN and_CC other_JJ reports_NNS ,_, subclavian_NN
        vein_NN approach_NN has_VBZ a_DT significant_JJ advantage_NN with_IN respect_NN to_TO
        insertion_NN site_NN colonization_NN and_CC infection_NN [_NN 6_CD 15_CD 16_CD ]_NN ._.
        Therefore_RB ,_, we_PRP suggest_VBP that_IN the_DT subclavian_NN approach_NN be_VB
        utilized_JJ preferentially_RB for_IN catheterization_NN ,_, provided_VBD a_DT
        serious_JJ bleeding_NN diathesis_NNS is_VBZ not_RB present_NN and_CC risk_NN of_IN
        pneumothorax_NN is_VBZ not_RB excessive_JJ ._.
        In_IN our_PRP$ study_NN the_DT CRI_NNP rate_NN was_VBD higher_JJR for_IN CVCs_NNP kept_VBD in_IN
        place_NN for_IN ≥_NN 8_CD days_NNS (_( 24_CD ._. 2_LS %_NN )_) in_IN comparison_NN to_TO catheters_NNS kept_VBD
        in_IN place_NN for_IN ≤_NN 7_CD days_NNS (_( 12_CD ._. 9_CD %_NN )_) (_( p_NN =_SYM 0_CD ._. 03_CD )_) ._. The_DT CVCs_NNP kept_VBD in_IN
        place_NN for_IN ≥_NN 8_CD days_NNS were_VBD associated_VBN with_IN approximately_RB two_CD
        times_NNS the_DT risk_NN of_IN infection_NN compared_VBN with_IN catheters_NNS kept_VBD in_IN
        place_NN for_IN ≤_NN 7_CD days_NNS ._. The_DT practise_NN of_IN routinely_RB changing_VBG
        catheters_NNS according_VBG to_TO some_DT defined_VBN time_NN period_NN to_TO reduce_VB
        the_DT risk_NN of_IN CRI_NNP is_VBZ commonly_RB referred_VBN to_TO as_IN "_'' scheduled_VBN "_''
        replacement_NN [_NN 3_CD 7_CD ]_NN ._. There_EX is_VBZ little_JJ or_CC no_DT support_NN from_IN
        the_DT literature_NN for_IN scheduled_VBN replacement_NN ,_, even_RB though_IN it_PRP
        continues_VBZ to_TO be_VB a_DT common_JJ clinical_JJ practice_NN ._. Cook_NNP et_CC al_NN
        looked_VBD at_IN the_DT evidence_NN for_IN scheduled_VBN replacement_NN using_VBG
        guide-wire_JJ exchanges_NNS and_CC /_NN or_CC new_JJ site_NN replacements_NNS [_NN 17_CD ]_NN ._.
        They_PRP found_VBD no_DT evidence_NN that_WDT scheduled_VBD replacement_NN ,_, using_VBG
        either_CC of_IN the_DT replacement_NN techniques_NNS ,_, at_IN three_CD days_NNS or_CC
        seven_CD days_NNS had_VBD any_DT advantage_NN over_IN a_DT replacement_NN based_VBN on_IN
        clinical_JJ indication_NN ._. The_DT other_JJ studies_NNS also_RB failed_VBD to_TO prove_VB
        any_DT reduction_NN of_IN CRI_NNP rates_NNS by_IN scheduled_VBN replacement_NN [_NN 18_CD 19_CD
        ]_NN ._. While_IN catheter_NN tip_NN colonization_NN and_CC CRI_NNP may_MD increase_VB
        with_IN CVC_NNP duration_NN controversy_NN still_RB exists_VBZ regarding_VBG
        scheduled_VBN changes_NNS ._.
        We_PRP found_VBD that_IN the_DT incidence_NN and_CC risk_NN of_IN CRI_NNP was_VBD lower_JJR in_IN
        patients_NNS using_VBG glycopeptide_NN antibiotic_JJ during_IN
        catheterization_NN in_IN comparison_NN to_TO patients_NNS who_WP were_VBD not_RB
        using_VBG these_DT antibiotics_NNS (_( p_NN =_SYM 0_CD ._. 005_CD )_) ._. Gram-positive_NNP cocci_NN ,_,
        particularly_RB coagulase-negative_JJ Staphylococci_NNP (_( CNS_NNP )_) and_CC 
        S_NNP ._. aureus_NN ,_, are_VBP responsible_JJ for_IN at_IN
        least_JJS two-thirds_NNS of_IN the_DT CRI_NNP [_NN 12_CD 20_CD ]_NN ._. Glycopeptide_NNP
        antibiotics_NNS are_VBP active_JJ against_IN Staphylococci_NNP ,_, including_VBG
        methicillin_NN resistant_JJ isolates_VBZ ,_, which_WDT was_VBD also_RB the_DT most_RBS
        frequently_RB isolated_VBN organism_NN in_IN our_PRP$ study_NN ._. Therefore_RB we_PRP
        searched_VBD the_DT effect_NN of_IN these_DT antibiotics_NNS against_IN CRI_NNP ._. There_EX
        is_VBZ a_DT lack_NN of_IN clarity_NN in_IN the_DT literature_NN about_IN the_DT definition_NN
        and_CC influence_NN of_IN antimicrobial_NN use_NN ._. There_EX are_VBP only_RB a_DT few_JJ
        reports_NNS that_IN ,_, antimicrobials_NNS administered_VBN at_IN the_DT time_NN of_IN or_CC
        immediately_RB after_IN insertion_NN of_IN a_DT CVC_NNP may_MD reduce_VB the_DT
        incidence_NN of_IN CRI_NNP [_NN 21_CD 22_CD 23_CD ]_NN ._. Other_JJ trials_NNS demonstrated_VBD
        no_DT benefit_NN of_IN such_JJ prophylaxis_NNS ._. [_NN 24_CD 25_CD 26_CD ]_NN ._. According_VBG to_TO
        our_PRP$ results_NNS ,_, it_PRP seems_VBZ that_IN their_PRP$ use_NN may_MD prevent_VB catheters_NNS
        from_IN infection_NN especially_RB with_IN Gram_NNP -_: positive_JJ cocci_NN ._. The_DT
        glycopeptide_NN antibiotics_NNS the_DT patients_NNS were_VBD using_VBG during_IN the_DT
        catheterization_NN seems_VBZ to_TO have_VB prophylactic_JJ effect_NN ._. This_DT
        study_NN also_RB concludes_VBZ that_IN patients_NNS using_VBG antibiotics_NNS
        effective_JJ against_IN Gram_NNP -_: positive_JJ cocci_NN during_IN
        catheterization_NN ,_, Gram_NNP -_: negative_JJ organisms_NNS should_MD also_RB be_VB
        suspected_VBN as_IN the_DT cause_NN of_IN CRI_NNP and_CC antibiotics_NNS which_WDT are_VBP
        also_RB effective_JJ against_IN these_DT pathogens_NNS should_MD be_VB started_VBN
        empirically_RB ._. Further_RB studies_VBZ are_VBP needed_VBN to_TO assess_VB the_DT
        additional_JJ benefit_NN afforded_VBN by_IN antimicrobials_NNS in_IN reducing_VBG
        CRI_NNP ._.
        In_IN this_DT prospective_JJ study_NN ,_, the_DT rate_NN of_IN CRI_NNP was_VBD found_VBN to_TO
        be_VB 16_CD ._. 7_CD %_NN ._. The_DT rate_NN of_IN catheter-related_JJ bloodstream_NN
        infections_NNS (_( CRBIs_NNP )_) and_CC exit_NN site_NN infection_NN was_VBD 12_CD %_NN and_CC 5_CD ._. 6_CD %_NN
        respectively_RB ._. Of_IN the_DT CRBIs_NNP ,_, 28_CD (_( 77_CD ._. 8_CD %_NN )_) were_VBD diagnosed_VBN as_IN
        D-CRB_NNP and_CC the_DT other_JJ 8_CD (_( 22_CD ._. 2_LS %_NN )_) were_VBD diagnosed_VBN as_IN P-CRB_NNP ._.
        P-CRB_NNP was_VBD diagnosed_VBN when_WRB bacteremia_NN and_CC clinical_JJ
        manifestations_NNS of_IN sepsis_NN resolved_VBN after_IN removal_NN of_IN
        implicated_VBN catheter_NN in_IN case_NN of_IN the_DT organism_NN causing_VBG
        bacteremia_NN not_RB identified_VBD at_IN any_DT other_JJ site_NN that_WDT is_VBZ
        possible_JJ source_NN ._. As_IN stated_VBN in_IN the_DT definition_NN of_IN P-CRB_NNP we_PRP
        could_MD not_RB isolate_VB the_DT responsible_JJ organisms_NNS causing_VBG
        bloodstream_NN infection_NN from_IN the_DT catheter_NN tip_NN in_IN
        approximately_RB 22_CD %_NN of_IN the_DT CRBI_NNP ._. It_PRP is_VBZ possible_JJ for_IN organisms_NNS
        to_TO originate_VB from_IN the_DT internal_JJ surface_NN or_CC the_DT hub_NN of_IN the_DT
        catheters_NNS ._. The_DT method_NN which_WDT we_PRP used_VBD to_TO culture_NN the_DT catheter_NN
        tip_NN (_( semiquantative_JJ method_NN )_) has_VBZ a_DT limitation_NN in_IN that_IN it_PRP can_MD
        take_VB samples_NNS only_RB from_IN the_DT external_JJ surfaces_VBZ of_IN catheters_NNS
        and_CC may_MD not_RB retrieve_VB organisms_NNS from_IN the_DT internal_JJ surfaces_VBZ
        of_IN the_DT catheters_NNS [_NN 10_CD ]_NN ._. Quantitative_NNP culture_NN techniques_NNS ,_,
        including_VBG the_DT sonication_NN and_CC vortexing_VBG methods_NNS [_NN 27_CD 28_CD 29_CD ]_NN
        ,_, have_VBP the_DT advantage_NN of_IN isolating_VBG organisms_NNS from_IN the_DT
        external_JJ and_CC internal_JJ surfaces_VBZ of_IN the_DT catheters_NNS and_CC
        possibly_RB releasing_VBG organisms_NNS embedded_VBN within_IN the_DT biofilm_NN
        layer_NN ._. Other_JJ reports_NNS comparing_VBG semiquantitative_JJ catheter_NN
        segment_NN culture_NN with_IN quantitative_JJ culture_NN methods_NNS supports_VBZ
        the_DT superiority_NN of_IN quantitative_JJ culture_NN methods_NNS [_NN 30_CD ]_NN ._.
        Thus_RB ,_, although_IN the_DT semiquantitative_JJ catheter_NN segment_NN
        culture_NN is_VBZ one_CD of_IN the_DT least_JJS expensive_JJ tests_NNS for_IN a_DT clinical_JJ
        microbiology_NN laboratory_NN to_TO perform_VB and_CC the_DT most_RBS frequently_RB
        used_VBN method_NN in_IN hospital_NN laboratories_NNS ,_, quantitative_JJ culture_NN
        methods_NNS should_MD be_VB preferred_VBN for_IN catheter_NN tip_NN culture_NN ._.
        A_DT number_NN of_IN investigators_NNS have_VBP examined_VBN the_DT microbiology_NN
        of_IN CRIs_NNP ._. 
        S_NNP ._. epidermidis_NNS were_VBD the_DT most_RBS common_JJ
        organism_NN growing_VBG followed_VBN by_IN 
        P_NN ._. aeruginosa_NN ,_, yeasts_NNS ,_, enterococci_NN ,_, 
        S_NNP ._. aureus_NN and_CC 
        Enterobacter_NNP spp_NN ._. [_NN 29_CD ]_NN ._. In_IN our_PRP$
        study_NN the_DT leading_VBG organism_NN causing_VBG CVC_NNP colonization_NN and_CC CRI_NNP
        was_VBD 
        S_NNP ._. aureus_NN followed_VBN by_IN 
        P_NN ._. aeruginosa_NN ,_, K_NNP ._. oxytoca_NN ,_, S_NNP ._.
        epidermidis_NNS and_CC 
        Acinetobacter_NNP spp_NN ._. Although_IN the_DT ratio_NN
        of_IN Gram-positive_NNP cocci_NN to_TO Gram-negative_NNP rods_NNS isolated_VBN from_IN
        all_DT catheters_NNS was_VBD approximately_RB 1_CD ,_, the_DT ratio_NN increased_VBD
        approximately_RB three_CD fold_VB in_IN CRI_NNP ._. The_DT finding_VBG that_IN 
        Staphylococcus_NNP spp_NN ._. was_VBD the_DT most_RBS
        common_JJ positive_JJ catheter_NN tip_NN isolate_VB seems_VBZ to_TO support_VB the_DT
        current_JJ view_NN that_DT infection_NN originates_VBZ either_CC from_IN the_DT
        patients_NNS own_JJ skin_NN flora_NNS or_CC that_IN of_IN medical_JJ personnel_NNS or_CC
        from_IN hub_NN colonization_NN ._.
      
      
        Conclusion_NNP
        Duration_NNP of_IN catheterization_NN and_CC catheter_NN insertion_NN site_NN
        were_VBD independent_JJ risk_NN factors_NNS for_IN catheter_NN related_VBD
        infection_NN ._. We_PRP found_VBD that_IN the_DT incidence_NN and_CC risk_NN of_IN CRI_NNP was_VBD
        lower_JJR in_IN patients_NNS who_WP were_VBD using_VBG glycopeptide_NN antibiotics_NNS
        during_IN catheterization_NN in_IN comparison_NN to_TO patients_NNS who_WP were_VBD
        not_RB using_VBG these_DT antibiotics_NNS ._. It_PRP seems_VBZ that_DT use_NN of_IN
        glycopeptide_NN antibiotics_NNS during_IN catheterization_NN has_VBZ a_DT
        protective_JJ effect_NN against_IN catheter_NN ralated_JJ infection_NN but_CC
        further_JJ studies_NNS are_VBP needed_VBN to_TO assess_VB the_DT benefit_NN ._. Although_IN
        the_DT semiquantitative_JJ catheter_NN segment_NN culture_NN is_VBZ one_CD of_IN the_DT
        least_JJS expensive_JJ tests_NNS for_IN a_DT clinical_JJ microbiology_NN
        laboratory_NN to_TO perform_VB and_CC the_DT most_RBS frequently_RB used_VBN method_NN
        in_IN hospital_NN laboratories_NNS ,_, quantitative_JJ culture_NN methods_NNS
        should_MD be_VB preferred_VBN for_IN catheter_NN tip_NN culture_NN ._.
      
      
        List_NN of_IN abbreviations_NNS used_VBN
        CVC_NNP Central_NNP venous_JJ catheter_NN
        CRI_NNP Catheter_NNP related_VBD infection_NN
        CFU_NNP Colony_NNP forming_VBG unit_NN
        CNS_NNP Coagulase_NNP negative_JJ Staphylococci_NNP
        TPN_NNP Total_JJ parenteral_NN nutrition_NN
        ICU_NNP Intensive_NNP care_NN unit_NN
        D-CRB_NNP Definite_NNP catheter_NN related_VBD bacteremia_NN
        P-CRB_NNP Possible_JJ catheter_NN related_VBD bacteremia_NN
      
      
        Authors_NNP '_'' contributions_NNS
        SÖ_NNP carried_VBD out_RP the_DT study_NN ,_, designed_VBD the_DT study_NN ,_, written_VBN
        the_DT manuscript_NN ._. HO_NNP designed_VBD the_DT study_NN ,_, supervised_JJ its_PRP$
        coordination_NN ._. AY_NNP participated_VBD in_IN carrying_VBG the_DT study_NN ._. PA_NNP
        performed_VBD the_DT statistical_JJ analysis_NN ._. NC_NNP participated_VBD in_IN
        design_NN and_CC coordination_NN ._. HE_PRP participated_VBD in_IN design_NN and_CC
        coordination_NN ._. SC_NNP participated_VBD in_IN design_NN and_CC
        coordination_NN ._.
      
    
  
